The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective
Open accessAbstract
animal models. The presence of amyloid beta (Aβ) has been shown to disrupt gliotransmission, neurotransmitter uptake, and alter calcium signaling in astrocytes. Furthermore, astrocytes express apolipoprotein E and are involved in the production, degradation and removal of Aβ. As well, changes in astrocytes that precede other pathological characteristics observed in AD, point to an early contribution of astroglia in this disease. Astrocytes participate in the inflammatory/immune responses of the central nervous system. The presence of Aβ activates different cell receptors and intracellular signaling pathways, mainly the advanced glycation end products receptor/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway, responsible for the transcription of pro-inflammatory cytokines and chemokines in astrocytes. The release of these pro-inflammatory agents may induce cellular damage or even stimulate the production of Aβ in astrocytes. Additionally, Aβ induces the appearance of oxidative stress (OS) and production of reactive oxygen species and reactive nitrogen species in astrocytes, affecting among others, intracellular calcium levels, NADPH oxidase (NOX), NF-κB signaling, glutamate uptake (increasing the risk of excitotoxicity) and mitochondrial function. Excessive neuroinflammation and OS are observed in AD, and astrocytes seem to be involved in both. The Aβ/NF-κB interaction in astrocytes may play a central role in these inflammatory and OS changes present in AD. In this paper, we also discuss therapeutic measures highlighting the importance of astrocytes in AD pathology. Several new therapeutic approaches involving phenols (curcumin), phytoestrogens (genistein), neuroesteroids and other natural phytochemicals have been explored in astrocytes, obtaining some promising results regarding cognitive improvements and attenuation of neuroinflammation. Novel strategies comprising astrocytes and aimed to reduce OS in AD have also been proposed. These include estrogen receptor agonists (pelargonidin), Bambusae concretio Salicea, Monascin, and various antioxidatives such as resveratrol, tocotrienol, anthocyanins, and epicatechin, showing beneficial effects in AD models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–274 of 274
Cirillo, C., Capoccia, E., Iuvone, T., Cuomo, R., Sarnelli, G., Steardo, L., & Esposito, G. (2015) · BioMed Research International · doi:10.1155/2015/508342 · Cited by 95
Jossan, S. S., Gillberg, P., Gottfries, C. G., Karlsson, I., & Oreland, L. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90098-9 · Cited by 95
Leuner, K., Stockburger, C., Denzer, I., Eckert, G. P., & Müller, W. E. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00007-6 · Cited by 94
Zhu, X., Yu, J., Jiang, T., Wang, P., Cao, L., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8723-8 · Cited by 94
Walker, D. G., Whetzel, A. M., Serrano, G., Sue, L. I., Beach, T. G., & Lue, L.-F. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.023 · Cited by 93 · cited 2×
“…and complement cascade have been considered risk factors for the development of AD and have been associated with abnormal clearing or deposition of A β ; in particular, variants in the genes complement receptor 1 (CR1) (Zhu et al., 2015), CD33 (Walker et al., 2015), and TREM2 (Yeh et al., 2016).”
BackgroundAskarova, S., Yang, X., Sheng, W., Sun, G. Y., & Lee, J. C.-M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.038 · Cited by 92
Xiu, J., Nordberg, A. K., Zhang, J., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.023 · Cited by 91
The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptide
Schubert, D. A., Soucek, T., & Blouw, B. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06712.x · Cited by 90
Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia
González-Reyes, R. E., Aliev, G., Ávila-Rodriguez, M., & Barreto, G. E. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151209152013 · Cited by 90
Self-citationPasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4510 · Cited by 89
Picomolar Amyloid-β Peptides Enhance Spontaneous Astrocyte Calcium Transients
Lee, L., Kosuri, P., & Arancio, O. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130740 · Cited by 89
Differential deregulation of astrocytic calcium signalling by amyloid-β, TNFα, IL-1β and LPS
Ronco, V., Grolla, A. A., Glasnov, T. N., Canonico, P. L., Verkhratsky, A., Genazzani, A. A., & Lim, D. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.02.016 · Cited by 89
Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
Batarseh, Y. S., Duong, Q.-V., Mousa, Y. M., Rihani, S. B. A., Elfakhri, K. H., & Kaddoumi, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030338 · Cited by 89
Mitochondrial dysfunction and Alzheimer's disease
Hu, L. (2013) · Zhongguo yaolixue tongbao · Cited by 86
β-Amyloid Protein Structure Determines the Nature of Cytokine Release From Rat Microglia
Lindberg, C., Selenica, M. B., Westlind‐Danielsson, A., & Schultzberg, M. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:001 · Cited by 83
Antioxidant effects of Epicatechin on the hippocampal toxicity caused by Amyloid-beta 25-35 in rats
Cuevas, E., Limón, I. D., Pérez‐Severiano, F., Díaz, A., Ortega, L., Zenteno, E., & Guevara, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.013 · Cited by 82
Lahiri, D. K., Chen, D., Vivien, D., Ge, Y.-W., Greig, N. H., & Rogers, J. T. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5203 · Cited by 81 · cited 1×
“Cytokines seem to act on the 5 -untranslated region (5 -UTR) of the APP gene in astrocytes (Lahiri et al., 2003).”
BackgroundCaselli, R. J., Beach, T. G., Knopman, D. S., & Graff-Radford, N. R. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.011 · Cited by 81 · cited 1×
“Regrettably none of these drugs is able to halt the progression of the disease and its uses are aimed at maximizing the quality of life of patients though broad symptom management (Caselli et al., 2017).”
BackgroundKawahara, M., & Kuroda, Y. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007168910582 · Cited by 81
Ishii, T., Takanashi, Y., Sugita, K., Miyazawa, M., Yanagihara, R., Yasuda, K., Onouchi, H., Kawabe, N., Nakata, M., Yamamoto, Y., et al. (2016) · Aging Cell · doi:10.1111/acel.12523 · Cited by 81
Reactive gliosis and monoamine oxidase B
Ekblom, J., Jossan, S. S., Oreland, L., Walum, E., & Aquilonius, S. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9324-2_33 · Cited by 79
Rodriguez‐Vieitez, E., Carter, S. F., Chiotis, K., Saint‐Aubert, L., Leuzy, A., Schöll, M., Almkvist, O., Wall, A. E., Långström, B., & Nordberg, A. K. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168732 · Cited by 79
Gajardo‐Gómez, R., Labra, V. C., Maturana, C. J., Shoji, K. F., Santibáñez, C. A., Sáez, J. C., Giaume, C., & Orellana, J. A. (2016) · Glia · doi:10.1002/glia.23080 · Cited by 79
Turillazzi, E., Neri, M., Cerretani, D., Cantatore, S., Frati, P., Moltoni, L., Busardò, F. P., Pomara, C., Riezzo, I., & Fineschi, V. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12748 · Cited by 78
Neuronal and Astrocytic Metabolism in a Transgenic Rat Model of Alzheimer's Disease
Nilsen, L. H., Witter, M. P., & Sonnewald, U. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.37 · Cited by 77
Sohanaki, H., Baluchnejadmojarad, T., Nikbakht, F., & Roghani, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.021 · Cited by 77
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease
Cudaback, E., Jorstad, N. L., Yang, Y. J., Montine, T. J., & Keene, C. D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.014 · Cited by 73
Bahniwal, M., Little, J. P., & Klegeris, A. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170117104053 · Cited by 72
Ueda, Y., Doi, T., Nagatomo, K., Tokumaru, J., Takaki, M., & Willmore, L. J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.021 · Cited by 72
Aguirre-Rueda, D., Guerra‐Ojeda, S., Aldasoro, M., Iradi, A., Obrador, E., Mauricio, M. D., Vila, J. M., Marchio, P., & Vallés, S. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122843 · Cited by 69
Wu, J., Hocevar, M., Foss, J. F., Bie, B., & Naguib, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.044 · Cited by 68
Ye, B., Shen, H., Zhang, J., Zhu, Y.-G., Ransom, B. R., Chen, X., & Ye, Z. (2015) · Glia · doi:10.1002/glia.22886 · Cited by 67
Physiological and pathological roles of the γ-secretase complex
Carroll, C. M., & Li, Y. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.019 · Cited by 67
Wang, H., Zhang, T., Huang, J., & Sun, X. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350139 · Cited by 65
van Gijsel-Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., de Reggi, M., & Gharib, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175369 · Cited by 63
Cohen‐Gadol, A., Pan, J. W., Kim, J., Spencer, D. D., & Hetherington, H. P. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.101.4.0613 · Cited by 62
Pierce, A. L., Bullain, S., & Kawas, C. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.006 · Cited by 58
The effects of amyloid-β42 oligomer on the proliferation and activation of astrocytes in vitro
Hou, L., Liu, Y., Wang, X., Ma, H., He, J., Zhang, Y., Yu, C.-H., Guan, W., & Ma, Y.-H. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9439-y · Cited by 57
Lemoine, L., Saint‐Aubert, L., Nennesmo, I., Gillberg, P., & Nordberg, A. K. (2017) · Scientific Reports · doi:10.1038/srep45496 · Cited by 56
He, Y., Jackman, N. A., Thorn, T. L., Vought, V. E., & Hewett, S. J. (2015) · Glia · doi:10.1002/glia.22828 · Cited by 55
Satoh, J.-I., Yamamoto, Y., Asahina, N., Kitano, S., & Kino, Y. (2014) · Disease Markers · doi:10.1155/2014/123165 · Cited by 53
Kumlien, E., Hilton‐Brown, P., Spännare, B., & Gillberg, P. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb02336.x · Cited by 53
Ibrahim, N. F., Yanagisawa, D., Durani, L. W., Hamezah, H. S., Damanhuri, H. A., Ngah, W. Z. W., Tsuji, M., Kiuchi, Y., Ono, K., & Tooyama, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160685 · Cited by 53
Sánchez‐Rodríguez, I., Temprano‐Carazo, S., López, A. N., Djebari, S., Yajeya, J., Gruart, A., Delgado-Garcia, J. M., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-15306-8 · Cited by 53
Anti-inflammatory effects of daidzein on primary astroglial cell culture
Liu, M.-H., Lin, Y.-S., Sheu, S.-Y., & Sun, J. (2009) · Nutritional Neuroscience · doi:10.1179/147683009x423274 · Cited by 52
Uittenbogaard, M. N., Baxter, K. K., & Chiaramello, A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22182 · Cited by 47
Toivari, E., Manninen, T., Nahata, A. K., Jalonen, T. O., & Linne, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017914 · Cited by 47
Hong, Y., Wang, X., Sun, S., Xue, G., Li, J., & Yan-ning, H. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.002 · Cited by 45
GLT-1 promoter activity in astrocytes and neurons of mouse hippocampus and somatic sensory cortex
de Vivo, L. (2010) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.031.2009 · Cited by 42
Liu, S., Wu, H., Xue, G., Ma, X., Wu, J., Qin, Y., & Hou, Y.-N. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.30.002 · Cited by 40
Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology
Beeri, M. S., Schmeidler, J., Lesser, G. T., Maroukian, M., West, R. K., Leung, S., Wysocki, M., Perl, D. P., Purohit, D. P., & Haroutunian, V. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.011 · Cited by 40
Parfenova, H., Tcheranova, D., Basuroy, S., Fedinec, A. L., Liu, J., & Leffler, C. W. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01011.2011 · Cited by 38
Astrocyte´s RAGE: More Than Just a Question of Mood
Gonzalez-Reyes, R. E., & Rubiano, M. G. (2018) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524916999160505105121 · Cited by 36
Wang, L., Wang, M., Hu, J., Shen, W., Hu, J., Yao, Y., Wang, X., Afzal, C. M., Ma, R., & Li, G. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.12.013 · Cited by 36
van Gijsel‐Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., Reggi, M. L. D., & Gharib, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194586 · Cited by 36
Misuraca, K. L., Barton, K. L., Chung, A., Diaz, A. K., Conway, S. J., Corcoran, D. L., Baker, S. J., & Becher, O. J. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0134-6 · Cited by 34
The neuroprotective efficacy of α-crystallin against acute inflammation in mice
Masilamoni, J. G., Vignesh, S., Kirubagaran, R., Jesudason, E. P., & Rajadas, J. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.07.002 · Cited by 33
Aisen, P., Thal, L. J., Ferris, S. H., Assaid, C. A., Nessly, M. L., Giuliani, M., Lines, C., Norman, B., & Potter, W. Z. (2008) · Current Alzheimer Research · doi:10.2174/156720508783884602 · Cited by 32
Lei, D.-L., Li, J., Zhang, Y. T., Tang, L., Chen, Y., Gao, Q., Bao, M., & Xiang, J. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.191224 · Cited by 32
Dorey, E., Bamji‐Mirza, M., Najem, D., Li, Y., Liu, H., Callaghan, D., Walker, D. G., Lue, L., Stanimirovic, D. B., & Zhang, W. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160133 · Cited by 30
Test-retest reproducibility of [11C]-l-deprenyl-D2 binding to MAO-B in the human brain
Arakawa, R., Stenkrona, P., Takano, A., Nag, S., Maior, R. S., & Halldin, C. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0301-4 · Cited by 30
Zhang, X., Luhrs, K. J., Ryff, K. A., Malik, W., Driscoll, M., & Culver, B. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.010 · Cited by 29
P4–029: Glutamate dysregulation in tau P301L mice
Hunsberger, H. C., Rudy, C. C., & Reed, M. N. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1417 · Cited by 29
Nanoparticle-emitted light attenuates amyloid-β-induced superoxide and inflammation in astrocytes
Bungart, B. L., Dong, L., Sobek, D., Sun, G. Y., Yao, G., & Lee, J. C.-M. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.10.007 · Cited by 27
Yarishkin, O. V., Lee, J., Jo, S., Hwang, E. M., & Lee, C. J. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.3.211 · Cited by 27
Makitani, K., Nakagawa, S., Izumi, Y., Akaike, A., & Kume, T. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.03.008 · Cited by 25
Jeong, J., Yoon, C.-H., Lee, W.-H., Park, K., Chang, Y., Choi, Y. H., & Kim, C. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.12.034 · Cited by 25
Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer’s Disease
Yun, H., Kim, J. A., Hwang, C. J., Jin, P., Baek, M. K., Lee, J., Hong, J. E., Lee, S. M., Han, S., Oh, K. W., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8860-0 · Cited by 23
Kommers, T. C., Rodnight, R., Boeck, C. R., Vendite, D., de Oliveira, D. L., Horn, J. F., Oppelt, D. M., & Wofchuk, S. T. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00434-0 · Cited by 22
Fowler, K. D., Funt, J. M., Artyomov, M. N., Zeskind, B. J., Kolitz, S. E., & Towfic, F. (2015) · Scientific Reports · doi:10.1038/srep14324 · Cited by 22
Masilamoni, J. G., Jesudason, E. P., Jesudoss, K. S., Murali, J., Paul, S. F. D., & Rajadas, J. (2005) · Free Radical Research · doi:10.1080/10715760500117373 · Cited by 18
Armato, U., Prà, I. D., & Chiarini, A. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.152373 · Cited by 18
Maeda, M., Takagi, H., Hattori, H., et al. (1997) · PubMed · Cited by 17
Mutis, J., Rodríguez, J. H., & Nava-Mesa, M. O. (2016) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2016.11.002 · Cited by 15
Self-citation
Cited by
Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044
Sadick, J. S., O’Dea, M. R., Hasel, P., Dykstra, T., Faustin, A., & Liddelow, S. A. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.008 · Cited by 415
Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8152373 · Cited by 403
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease
Sun, E., Motolani, A., Campos, L., & Lu, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168972 · Cited by 361
Astrocytes: Role and Functions in Brain Pathologies
Siracusa, R., Fusco, R., & Cuzzocrea, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01114 · Cited by 340
Metadata
- Authors
- González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-12-19
- Volume
- 10
- Pages
- 427-427
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2776096008
- Cited by
- 527
- References
- 274
- FWCI
- 24.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.